Cargando...
Antithrombotic therapy in diabetes: which, when, and for how long?
Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, contributes to the high vascular risk in individual...
Guardado en:
| Publicado en: | Eur Heart J |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203081/ https://ncbi.nlm.nih.gov/pubmed/33764414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehab128 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|